Neill Giese, Ph.D.

Chief Scientific Officer

Neill Giese has been the Chief Scientific Officer at Calistoga Pharmaceuticals since he co-founded the company in 2006. Dr. Giese has 18 years of experience in drug discovery and development in oncology, inflammation and vascular biology with a focus on mechanism-based targeted therapies for the treatment of hematologic malignancies. Prior to Calistoga, Dr. Giese was Senior Vice President of Biological Sciences and Drug Development at SGX Inc. Prior to SGX, Dr. Giese was one of the founding scientists at COR Therapeutics, Inc. in 1989, most recently serving as Senior Director of Cancer and Cardiovascular Biology continuing in that position after it was acquired by Millennium Pharmaceuticals.

Dr. Giese received his Bachelor of Science degree in Pharmacy and Masters of Science degree in Pharmacology and Toxicology from Oregon State University and his doctorate in Pharmacology from University of Arizona. He undertook his postdoctoral training at the National Cancer Institute, National Institutes of Health in the laboratory of Dr. Stuart Aaronson.